A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage (Q44135617)

30 November 2017

title

A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage (English)

1 reference

polycystic ovary syndrome

30 November 2017

0 references

1 reference

1 reference

Karen A Cocksedge

1

1 reference

30 November 2017

Tin-Chiu Li

series ordinal

2

1 reference

30 November 2017

Sotiris H Saravelos

series ordinal

3

1 reference

30 November 2017

Mostafa Metwally

series ordinal

4

1 reference

30 November 2017

publication date

1 July 2008

1 reference

Reproductive BioMedicine Online

30 November 2017

published in

1 reference

30 November 2017

volume

17

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

151-160

1 reference

The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Ultrasound assessment of the polycystic ovary: international consensus definitions.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Obesity and the risk of spontaneous abortion after oocyte donation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The effect of serum follicular phase luteinizing hormone concentrations in habitual abortion: correlation with results of paternal leukocyte immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Definition and significance of polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Development, pharmacology and clinical experience with clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Incidence of spontaneous abortion in clomiphene pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Insulin resistance in women with recurrent spontaneous miscarriage of unknown aetiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The aetiology and pattern of recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The prevalence of polycystic ovaries in women with infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Modern use of clomiphene citrate in induction of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Congenital malformations of newborn infants after clomiphene-induced ovulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Recurrent miscarriage: aetiology, management and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Use of human menopausal gonadotropins in the treatment of endometrial defects associated with recurrent miscarriage: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Endocrinological and endometrial factors in recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Further Clinical Experience with Clomiphene Citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The impact of obesity on female reproductive function.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovaries and recurrent miscarriage--a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The Presence of Gonadotropin Receptors in Nonpregnant Human Uterus, Human Placenta, Fetal Membranes, and Decidua*

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Recurrent early miscarriage and polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Diagnosis of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960304-5

7 January 2021

10.1016/S1472-6483(10)60304-5

Identifiers

DOI

1 reference

30 November 2017

1 reference